0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global and United States Human Microbiome Modulators Market Report & Forecast 2022-2028
Published Date: June 2022
|
Report Code: QYRE-Auto-30P5716
Home | Market Reports | Science | Biological Sciences
Global and United States Human Microbiome Modulators Market Report Forecast 2022 2028

Global and United States Human Microbiome Modulators Market Report & Forecast 2022-2028

Code: QYRE-Auto-30P5716
Report
June 2022
98 Pages
QYResearch
Region: Global,
Description
Table of Content
Tables & Figures
The human microbiota is an aggregate of microorganisms residing in the human body, mostly in the gastrointestinal tract.
Market Analysis and Insights: Global and United States Human Microbiome Modulators Market
This report focuses on global and United States Human Microbiome Modulators market, also covers the segmentation data of other regions in regional level and county level.

Due to the COVID-19 pandemic, the global Human Microbiome Modulators market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period.

Fully considering the economic change by this health crisis, by Type, Probiotics and Creams accounting for % of the Human Microbiome Modulators global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period.

While by Application, Digestive Health was the leading segment, accounting for over percent market share in 2021, and altered to an % CAGR throughout this forecast period.

In United States the Human Microbiome Modulators market size is expected to grow from US$ million in 2021 to US$ million by 2028, at a CAGR of % during the forecast period.

Global Human Microbiome Modulators Scope and Market Size
Human Microbiome Modulators market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Human Microbiome Modulators market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
For United States market, this report focuses on the Human Microbiome Modulators market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.

Segment by Type

Probiotics and Creams
Prebiotics and Dietary Supplements
Drugs

Segment by Application

Digestive Health
Immune Health
Oral Health
Others

BY REGION

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E

BY COMPANY

Bayer
BioGaia
Chr. Hansen Holding
DowDuPont
Ingredion
ISOThrive
Jarrow Formulas
DSM
Lallemand
Sanofi
1 Study Coverage
1.1 Human Microbiome Modulators Revenue in Human Microbiome Modulators Business (2017-2022) & (US$ Million) Introduction
1.2 Global Human Microbiome Modulators Outlook 2017 VS 2022 VS 2028
1.2.1 Global Human Microbiome Modulators Market Size for the Year 2017-2028
1.2.2 Global Human Microbiome Modulators Market Size for the Year 2017-2028
1.3 Human Microbiome Modulators Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.3.1 The Market Share of United States Human Microbiome Modulators in Global, 2017 VS 2022 VS 2028
1.3.2 The Growth Rate of Human Microbiome Modulators Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4 Human Microbiome Modulators Market Dynamics
1.4.1 Human Microbiome Modulators Industry Trends
1.4.2 Human Microbiome Modulators Market Drivers
1.4.3 Human Microbiome Modulators Market Challenges
1.4.4 Human Microbiome Modulators Market Restraints
1.5 Study Objectives
1.6 Years Considered
2 Human Microbiome Modulators by Type
2.1 Human Microbiome Modulators Market Segment by Type
2.1.1 Probiotics and Creams
2.1.2 Prebiotics and Dietary Supplements
2.1.3 Drugs
2.2 Global Human Microbiome Modulators Market Size by Type (2017, 2022 & 2028)
2.3 Global Human Microbiome Modulators Market Size by Type (2017-2028)
2.4 United States Human Microbiome Modulators Market Size by Type (2017, 2022 & 2028)
2.5 United States Human Microbiome Modulators Market Size by Type (2017-2028)
3 Human Microbiome Modulators by Application
3.1 Human Microbiome Modulators Market Segment by Application
3.1.1 Digestive Health
3.1.2 Immune Health
3.1.3 Oral Health
3.1.4 Others
3.2 Global Human Microbiome Modulators Market Size by Application (2017, 2022 & 2028)
3.3 Global Human Microbiome Modulators Market Size by Application (2017-2028)
3.4 United States Human Microbiome Modulators Market Size by Application (2017, 2022 & 2028)
3.5 United States Human Microbiome Modulators Market Size by Application (2017-2028)
4 Global Human Microbiome Modulators Competitor Landscape by Company
4.1 Global Human Microbiome Modulators Market Size by Company
4.1.1 Top Global Human Microbiome Modulators Companies Ranked by Revenue (2021)
4.1.2 Global Human Microbiome Modulators Revenue by Player (2017-2022)
4.2 Global Human Microbiome Modulators Concentration Ratio (CR)
4.2.1 Human Microbiome Modulators Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Companies of Human Microbiome Modulators in 2021
4.2.3 Global Human Microbiome Modulators Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Human Microbiome Modulators Headquarters, Revenue in Human Microbiome Modulators Business (2017-2022) & (US$ Million) Type
4.3.1 Global Human Microbiome Modulators Headquarters and Area Served
4.3.2 Global Human Microbiome Modulators Companies Revenue in Human Microbiome Modulators Business (2017-2022) & (US$ Million) Type
4.3.3 Date of International Companies Enter into Human Microbiome Modulators Market
4.4 Companies Mergers & Acquisitions, Expansion Plans
4.5 United States Human Microbiome Modulators Market Size by Company
4.5.1 Top Human Microbiome Modulators Players in United States, Ranked by Revenue (2021)
4.5.2 United States Human Microbiome Modulators Revenue by Players (2020, 2021 & 2022)
5 Global Human Microbiome Modulators Market Size by Region
5.1 Global Human Microbiome Modulators Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Human Microbiome Modulators Market Size by Region (2017-2028)
5.2.1 Global Human Microbiome Modulators Market Size by Region: 2017-2022
5.2.2 Global Human Microbiome Modulators Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Human Microbiome Modulators Market Size YoY Growth 2017-2028
6.1.2 North America Human Microbiome Modulators Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Human Microbiome Modulators Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Human Microbiome Modulators Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Human Microbiome Modulators Market Size YoY Growth 2017-2028
6.3.2 Europe Human Microbiome Modulators Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Human Microbiome Modulators Market Size YoY Growth 2017-2028
6.4.2 Latin America Human Microbiome Modulators Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Human Microbiome Modulators Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Human Microbiome Modulators Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 Bayer
7.1.1 Bayer Company Details
7.1.2 Bayer Business Overview
7.1.3 Bayer Human Microbiome Modulators Introduction
7.1.4 Bayer Revenue in Human Microbiome Modulators Business (2017-2022)
7.1.5 Bayer Recent Development
7.2 BioGaia
7.2.1 BioGaia Company Details
7.2.2 BioGaia Business Overview
7.2.3 BioGaia Human Microbiome Modulators Introduction
7.2.4 BioGaia Revenue in Human Microbiome Modulators Business (2017-2022)
7.2.5 BioGaia Recent Development
7.3 Chr. Hansen Holding
7.3.1 Chr. Hansen Holding Company Details
7.3.2 Chr. Hansen Holding Business Overview
7.3.3 Chr. Hansen Holding Human Microbiome Modulators Introduction
7.3.4 Chr. Hansen Holding Revenue in Human Microbiome Modulators Business (2017-2022)
7.3.5 Chr. Hansen Holding Recent Development
7.4 DowDuPont
7.4.1 DowDuPont Company Details
7.4.2 DowDuPont Business Overview
7.4.3 DowDuPont Human Microbiome Modulators Introduction
7.4.4 DowDuPont Revenue in Human Microbiome Modulators Business (2017-2022)
7.4.5 DowDuPont Recent Development
7.5 Ingredion
7.5.1 Ingredion Company Details
7.5.2 Ingredion Business Overview
7.5.3 Ingredion Human Microbiome Modulators Introduction
7.5.4 Ingredion Revenue in Human Microbiome Modulators Business (2017-2022)
7.5.5 Ingredion Recent Development
7.6 ISOThrive
7.6.1 ISOThrive Company Details
7.6.2 ISOThrive Business Overview
7.6.3 ISOThrive Human Microbiome Modulators Introduction
7.6.4 ISOThrive Revenue in Human Microbiome Modulators Business (2017-2022)
7.6.5 ISOThrive Recent Development
7.7 Jarrow Formulas
7.7.1 Jarrow Formulas Company Details
7.7.2 Jarrow Formulas Business Overview
7.7.3 Jarrow Formulas Human Microbiome Modulators Introduction
7.7.4 Jarrow Formulas Revenue in Human Microbiome Modulators Business (2017-2022)
7.7.5 Jarrow Formulas Recent Development
7.8 DSM
7.8.1 DSM Company Details
7.8.2 DSM Business Overview
7.8.3 DSM Human Microbiome Modulators Introduction
7.8.4 DSM Revenue in Human Microbiome Modulators Business (2017-2022)
7.8.5 DSM Recent Development
7.9 Lallemand
7.9.1 Lallemand Company Details
7.9.2 Lallemand Business Overview
7.9.3 Lallemand Human Microbiome Modulators Introduction
7.9.4 Lallemand Revenue in Human Microbiome Modulators Business (2017-2022)
7.9.5 Lallemand Recent Development
7.10 Sanofi
7.10.1 Sanofi Company Details
7.10.2 Sanofi Business Overview
7.10.3 Sanofi Human Microbiome Modulators Introduction
7.10.4 Sanofi Revenue in Human Microbiome Modulators Business (2017-2022)
7.10.5 Sanofi Recent Development
8 Research Findings and Conclusion
9 Appendix
9.1 Research Methodology
9.1.1 Methodology/Research Approach
9.1.2 Data Source
9.2 Author Details
9.3 Disclaimer
List of Tables
    Table 1. Human Microbiome Modulators Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
    Table 2. Human Microbiome Modulators Market Trends
    Table 3. Human Microbiome Modulators Market Drivers
    Table 4. Human Microbiome Modulators Market Challenges
    Table 5. Human Microbiome Modulators Market Restraints
    Table 6. Global Human Microbiome Modulators Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Human Microbiome Modulators Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Human Microbiome Modulators Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Human Microbiome Modulators Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Human Microbiome Modulators Companies in Global Market, Ranking by Revenue (2021)
    Table 11. Global Human Microbiome Modulators Revenue by Player, (US$ Million), 2017-2022
    Table 12. Global Human Microbiome Modulators Revenue Share by Player, 2017-2022
    Table 13. Global Human Microbiome Modulators Companies Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Human Microbiome Modulators by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Microbiome Modulators as of 2021)
    Table 15. Top Players of Human Microbiome Modulators in Global Market, Headquarters and Area Served
    Table 16. Companies Revenue in Human Microbiome Modulators Business (2017-2022) & (US$ Million) Type
    Table 17. Date of International Companies Enter into Human Microbiome Modulators Market
    Table 18. Companies Mergers & Acquisitions, Expansion Plans
    Table 19. Top Human Microbiome Modulators Players in United States Market, Ranking by Revenue (2021)
    Table 20. United States Human Microbiome Modulators Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 21. United States Human Microbiome Modulators Revenue Share by Players, 2020, 2021 & 2022
    Table 22. Global Human Microbiome Modulators Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 23. Global Human Microbiome Modulators Market Size by Region (2017-2022) & (US$ Million)
    Table 24. Global Human Microbiome Modulators Market Size Forecast by Region (2023-2028) & (US$ Million)
    Table 25. North America Human Microbiome Modulators Sales in Value by Country (2017-2028) & (US$ Million)
    Table 26. Asia Pacific Human Microbiome Modulators Sales in Value by Region (2017-2028) & (US$ Million)
    Table 27. Europe Human Microbiome Modulators Sales in Value by Country (2017-2028) & (US$ Million)
    Table 28. Latin Americaa Human Microbiome Modulators Sales in Value by Country (2017-2028) & (US$ Million)
    Table 29. Middle East and Africa Human Microbiome Modulators Sales in Value by Country (2017-2028) & (US$ Million)
    Table 30. Bayer Company Details
    Table 31. Bayer Business Overview
    Table 32. Bayer Human Microbiome Modulators Product
    Table 33. Bayer Revenue in Human Microbiome Modulators Business (2017-2022) & (US$ Million)
    Table 34. Bayer Recent Development
    Table 35. BioGaia Company Details
    Table 36. BioGaia Business Overview
    Table 37. BioGaia Human Microbiome Modulators Product
    Table 38. BioGaia Revenue in Human Microbiome Modulators Business (2017-2022) & (US$ Million)
    Table 39. BioGaia Recent Development
    Table 40. Chr. Hansen Holding Company Details
    Table 41. Chr. Hansen Holding Business Overview
    Table 42. Chr. Hansen Holding Human Microbiome Modulators Product
    Table 43. Chr. Hansen Holding Revenue in Human Microbiome Modulators Business (2017-2022) & (US$ Million)
    Table 44. Chr. Hansen Holding Recent Development
    Table 45. DowDuPont Company Details
    Table 46. DowDuPont Business Overview
    Table 47. DowDuPont Human Microbiome Modulators Product
    Table 48. DowDuPont Revenue in Human Microbiome Modulators Business (2017-2022) & (US$ Million)
    Table 49. DowDuPont Recent Development
    Table 50. Ingredion Company Details
    Table 51. Ingredion Business Overview
    Table 52. Ingredion Human Microbiome Modulators Product
    Table 53. Ingredion Revenue in Human Microbiome Modulators Business (2017-2022) & (US$ Million)
    Table 54. Ingredion Recent Development
    Table 55. ISOThrive Company Details
    Table 56. ISOThrive Business Overview
    Table 57. ISOThrive Human Microbiome Modulators Product
    Table 58. ISOThrive Revenue in Human Microbiome Modulators Business (2017-2022) & (US$ Million)
    Table 59. ISOThrive Recent Development
    Table 60. Jarrow Formulas Company Details
    Table 61. Jarrow Formulas Business Overview
    Table 62. Jarrow Formulas Human Microbiome Modulators Product
    Table 63. Jarrow Formulas Revenue in Human Microbiome Modulators Business (2017-2022) & (US$ Million)
    Table 64. Jarrow Formulas Recent Development
    Table 65. DSM Company Details
    Table 66. DSM Business Overview
    Table 67. DSM Human Microbiome Modulators Product
    Table 68. DSM Revenue in Human Microbiome Modulators Business (2017-2022) & (US$ Million)
    Table 69. DSM Recent Development
    Table 70. Lallemand Company Details
    Table 71. Lallemand Business Overview
    Table 72. Lallemand Human Microbiome Modulators Product
    Table 73. Lallemand Revenue in Human Microbiome Modulators Business (2017-2022) & (US$ Million)
    Table 74. Lallemand Recent Development
    Table 75. Sanofi Company Details
    Table 76. Sanofi Business Overview
    Table 77. Sanofi Human Microbiome Modulators Product
    Table 78. Sanofi Revenue in Human Microbiome Modulators Business (2017-2022) & (US$ Million)
    Table 79. Sanofi Recent Development
    Table 80. Research Programs/Design for This Report
    Table 81. Key Data Information from Secondary Sources
    Table 82. Key Data Information from Primary Sources
List of Figures
    Figure 1. Human Microbiome Modulators Product Picture
    Figure 2. Global Human Microbiome Modulators Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Human Microbiome Modulators Market Size 2017-2028 (US$ Million)
    Figure 4. United States Human Microbiome Modulators Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 5. United States Human Microbiome Modulators Market Size 2017-2028 (US$ Million)
    Figure 6. United States Human Microbiome Modulators Market Share in Global 2017-2028
    Figure 7. Human Microbiome Modulators Report Years Considered
    Figure 8. Product Picture of Probiotics and Creams
    Figure 9. Product Picture of Prebiotics and Dietary Supplements
    Figure 10. Product Picture of Drugs
    Figure 11. Global Human Microbiome Modulators Market Share by Type in 2022 & 2028
    Figure 12. Global Human Microbiome Modulators Market Size by Type (2017-2028) & (US$ Million)
    Figure 13. Global Human Microbiome Modulators Market Share by Type (2017-2028)
    Figure 14. United States Human Microbiome Modulators Market Share by Type in 2022 & 2028
    Figure 15. United States Human Microbiome Modulators Market Size by Type (2017-2028) & (US$ Million)
    Figure 16. United States Human Microbiome Modulators Market Share by Type (2017-2028)
    Figure 17. Product Picture of Digestive Health
    Figure 18. Product Picture of Immune Health
    Figure 19. Product Picture of Oral Health
    Figure 20. Product Picture of Others
    Figure 21. Global Human Microbiome Modulators Market Share by Application in 2022 & 2028
    Figure 22. Global Human Microbiome Modulators Market Size by Application (2017-2028) & (US$ Million)
    Figure 23. Global Human Microbiome Modulators Market Share by Application (2017-2028)
    Figure 24. United States Human Microbiome Modulators Market Share by Application in 2022 & 2028
    Figure 25. United States Human Microbiome Modulators Market Size by Application (2017-2028) & (US$ Million)
    Figure 26. United States Human Microbiome Modulators Market Share by Application (2017-2028)
    Figure 27. North America Human Microbiome Modulators Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 28. U.S. Human Microbiome Modulators Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 29. Canada Human Microbiome Modulators Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 30. Europe Human Microbiome Modulators Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 31. Germany Human Microbiome Modulators Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 32. France Human Microbiome Modulators Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 33. U.K. Human Microbiome Modulators Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 34. Italy Human Microbiome Modulators Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 35. Russia Human Microbiome Modulators Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 36. Asia-Pacific Human Microbiome Modulators Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 37. China Human Microbiome Modulators Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 38. Japan Human Microbiome Modulators Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 39. South Korea Human Microbiome Modulators Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 40. India Human Microbiome Modulators Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 41. Australia Human Microbiome Modulators Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 42. Taiwan Human Microbiome Modulators Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Indonesia Human Microbiome Modulators Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Thailand Human Microbiome Modulators Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Malaysia Human Microbiome Modulators Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 46. Philippines Human Microbiome Modulators Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 47. Latin America Human Microbiome Modulators Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 48. Mexico Human Microbiome Modulators Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Brazil Human Microbiome Modulators Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Argentina Human Microbiome Modulators Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Middle East & Africa Human Microbiome Modulators Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 52. Turkey Human Microbiome Modulators Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 53. Saudi Arabia Human Microbiome Modulators Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 54. U.A.E Human Microbiome Modulators Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 55. Bayer Revenue Growth Rate in Human Microbiome Modulators Business (2017-2022)
    Figure 56. BioGaia Revenue Growth Rate in Human Microbiome Modulators Business (2017-2022)
    Figure 57. Chr. Hansen Holding Revenue Growth Rate in Human Microbiome Modulators Business (2017-2022)
    Figure 58. DowDuPont Revenue Growth Rate in Human Microbiome Modulators Business (2017-2022)
    Figure 59. Ingredion Revenue Growth Rate in Human Microbiome Modulators Business (2017-2022)
    Figure 60. ISOThrive Revenue Growth Rate in Human Microbiome Modulators Business (2017-2022)
    Figure 61. Jarrow Formulas Revenue Growth Rate in Human Microbiome Modulators Business (2017-2022)
    Figure 62. DSM Revenue Growth Rate in Human Microbiome Modulators Business (2017-2022)
    Figure 63. Lallemand Revenue Growth Rate in Human Microbiome Modulators Business (2017-2022)
    Figure 64. Sanofi Revenue Growth Rate in Human Microbiome Modulators Business (2017-2022)
    Figure 65. Bottom-up and Top-down Approaches for This Report
    Figure 66. Data Triangulation
    Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$4350
This license allows only one user to access the PDF.

Electronic (PDF)
$6525
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Electronic (PDF)
$8700
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
SIS Group of Schools
SIMILAR REPORTS
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Insect Cell Culture Medium Market Research Report 2022
Global Insect Cell Culture Medium Market Research Report 2022

120 Pages
Type: Report
Code: QYRE-Auto-35A11450
Thu Aug 11 00:00:00 UTC 2022

Add to Cart

Global Cortical Grid Electrodes Market Research Report 2022
Global Cortical Grid Electrodes Market Research Report 2022

120 Pages
Type: Report
Code: QYRE-Auto-17U11756
Thu Aug 11 00:00:00 UTC 2022

Add to Cart

Global Cysteine Protease Market Research Report 2022
Global Cysteine Protease Market Research Report 2022

120 Pages
Type: Report
Code: QYRE-Auto-30L11388
Thu Aug 11 00:00:00 UTC 2022

Add to Cart

Global and Japan Brefeldin A Market Insights Forecast to 2027
Global Brefeldin A Market Research Report 2022

120 Pages
Type: Report
Code: QYRE-Auto-16B8424
Wed Aug 10 00:00:00 UTC 2022

Add to Cart